Haig P. Bozigian
Chief Development Officer
Neurology
Neurocrine Biosciences
United States of America
Biography
Dr. Haig P. Bozigian Ph.D., has been the Chief Development Officer of Neurocrine Biosciences, Inc. since December 21, 2006. Dr. Bozigian is responsible for all preclinical, chemical and pharmaceutical development at Neurocrine Biosciences. Dr. Bozigian joined Neurocrine in 1997 and served as its Vice President of Preclinical Development. Dr. Bozigian has extensive expertise in CNS related new product development, Dr. Bozigian has participated in research and development for more than 20 years. Dr. Bozigian served as Director of Pharmaceutical Development at Procyte Corporation, Associate Director of Pharmacokinetics and Drug Metabolism at Sphinx Pharmaceuticals and Clinical Pharmacokineticist at GlaxoSmithKline. Dr. Bozigian holds a BS degree in Microbiology from the University of Massachusetts, MS degree in Pharmacodynamics & Toxicology from the University of Nebraska Medical Center and a Ph.D. degree in Pharmaceutical Sciences from the University of Arizona.
Research Interest
Neuroinfectious Diseases
